Sequel’s twiist will become the first automated insulin delivery system to integrate with Senseonics' one-year CGM system.

Medtronic expanded its Touch Surgery Ecosystem (TSE) in April 2024 by launching the Live Stream function in the training app.

Metrion has launched the NaV1.9 screening assay, aimed at progressing the discovery along with the development of new pain ...

The letter acknowledged the potential of brain-computer interface technology yet noted that neurotech collects brain data ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology ...

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF System.

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...